Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Recruiting 3Active not recruiting 2Terminated 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Thoracic 6Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neoplasms 7Lung Neoplasms 6Colorectal Neoplasms 5Prostatic Neoplasms 3Smoking Cessation 2Neoplasm Metastasis 2Lymphoma 2Colonic Neoplasms 2Breast Neoplasms 2Uveal Melanoma 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Retroviridae Infections 1Pulmonary Disease, Chronic Obstructive 1Pancreatic cancer, adult 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasm, Residual 1Multiple Myeloma 1Motor Activity 1Leukemia 1Inflammation 1Glioblastoma 1Esophageal Neoplasms 1Dyspnea 1Disease 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 88Carboplatin 77Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 59Cisplatin 47durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Practice Guidelines as Topic 18Radiation 17Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Lung Neoplasms × Hematologic Tests × 1 year × Clear all
NCT07623473 2026-06-03

NIMBLE

Herlev and Gentofte Hospital

Recruiting
1,800 enrolled
Thoracic

Solitary Pulmonary Nodule, Disease, Lung Neoplasms

NCT01687647 2026-05-29

AMORCE-CBP

University Hospital, Caen

Phase 3 Terminated
463 enrolled
Thoracic

Lung Neoplasms

NCT06620835 2026-04-29

OPTALK

Groupe Francais De Pneumo-Cancerologie

Phase 2 Recruiting
45 enrolled
Thoracic

Lung Neoplasms

NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05766046 2026-03-27

RISP

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting
7,324 enrolled
Thoracic

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT06717295 2026-01-02

CCANED-CIPHER

Dysplasia Diagnostics Limited

Recruiting
6,000 enrolled
CNSGastrointestinalGenitourinaryGynecologicThoracic

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡